Bringing Vioxx back to market

BMJ. 2018 Jan 25:360:k242. doi: 10.1136/bmj.k242.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arthralgia / drug therapy*
  • Arthralgia / etiology
  • Drug Approval*
  • Hemophilia A / complications
  • Humans
  • Lactones / adverse effects*
  • Safety-Based Drug Withdrawals*
  • Sulfones / adverse effects*

Substances

  • Lactones
  • Sulfones
  • rofecoxib